Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $5,287 - $6,057
-403 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$13.54 - $15.35 $5,456 - $6,186
403 New
403 $6,000
Q4 2021

Feb 15, 2022

SELL
$13.17 - $16.4 $5,307 - $6,609
-403 Closed
0 $0
Q4 2020

Feb 18, 2021

SELL
$15.39 - $18.97 $1,462 - $1,802
-95 Reduced 19.08%
403 $7,000
Q3 2020

Nov 16, 2020

BUY
$17.1 - $19.19 $1,624 - $1,823
95 Added 23.57%
498 $9,000
Q1 2020

May 18, 2020

BUY
$13.02 - $20.31 $5,247 - $8,184
403 New
403 $6,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.8B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.